Alimta 500 mg Injection

Brand Name: Alimta

Molecule: Pemetrexed

Strength: 500 mg

Quantity: 1 Vial

Form: Injection

Packaging Type: Vial

Manufacturer/Marketed By: Eli Lilly And Company

Country of Origin: India

No similar products found.

Overview

- Introduction
- Benefits
- Indications and Usage
- How it Works
- Dosage & Administration
- Side Effects
- Warning and Precaution

Description

Alimta 500mg Injection contains Pemetrexed, a chemotherapy medicine used to treat non-small cell lung cancer and malignant pleural mesothelioma. It slows cancer cell growth and is administered under oncologist supervision.

Benefits

Helps slow cancer growth and spread
Improves treatment outcomes in eligible lung cancer patients
Effective when combined with platinum-based chemotherapy
Well-established standard of care in NSCLC and mesothelioma

Indications and Usage

Alimta 500mg Injection is indicated for:

Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Malignant Pleural Mesothelioma
May be used alone or in combination with other chemotherapy medicines (e.g., cisplatin)

Therapy must be initiated and supervised by an oncologist.

How it Works

Pemetrexed inhibits multiple folate-dependent enzymes required for DNA and RNA synthesis. By blocking these pathways, it prevents cancer cells from dividing and growing, leading to tumor control.

Dosage & Administration

Dose determined based on body surface area (BSA) and clinical condition
Given as an intravenous infusion every 3 weeks
Folic acid, vitamin B12, and corticosteroids are typically prescribed before treatment
Do not self-administer—must be given in a medical facility
Requires regular blood tests and kidney function monitoring